Good Quarter for IMS Health

Pharma data giant IMS Health has announced results for the quarter ended March 31st, with revenue up 7.0% at constant currency, to $632m and profit also jumping - adjusted EBITDA was $216n, up 9.8% at constant currency.

The reported figures were down 2.0% and 0.5% respectively, due to the strong dollar. IMS said revenue for its technology services led the way with a 12.7% constant currency rise (5.3% reported); while information offerings revenue rose 3.0% at constant currency (down 7.0% reported). Both emerging (11.2%) and developed markets (6.1%) saw revenue rise at constant currency.

Chairman and CEO Ari Bousbib (pictured) said of the results: 'We are pleased to report yet another quarter of strong operating performance, with our technology services offerings again growing double digits at constant currency. Important contract wins during the quarter position us well to continue this momentum.'

For the full year 2015, the company expects its core business (excluding the impact of the acquisition of Cegedim's CRM and Strategic Data businesses) to grow revenue 5 to 6 percent and adjusted EBITDA 7.5 to 8.5 percent, on a constant currency basis.

The results continue a good run for the company - in February it announced full year 2014 revenue up 5.9% at constant currency to $2,641m; EBITDA up 9.5%. Web site: www.imshealth.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• IMS Health Inc
• All news